Skip to main content
Clinical Trials/NCT01708434
NCT01708434
Completed
Not Applicable

Feasibility Study: Evaluation of the Ulthera® System for Lifting and Tightening of the Knees

Ulthera, Inc1 site in 1 country30 target enrollmentJune 2011
ConditionsSkin Laxity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Skin Laxity
Sponsor
Ulthera, Inc
Enrollment
30
Locations
1
Primary Endpoint
Improvement in overall lifting and tightening of knee skin laxity.
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Enrolled subjects will receive one bilateral Ulthera® treatment on the knees. Up to 30 subjects will be enrolled. Study photos will be obtained prior to study treatment, immediately following study treatment, and at each post-treatment follow-up visit. Follow-up visits will occur at 90 and 180 days post-treatment.

Detailed Description

This pilot study is a prospective, single-center clinical trial of the Ulthera® System for treating skin laxity on the knees. Global Aesthetic Improvement Scale scores and Patient Satisfaction questionnaires will be obtained at each follow-up visit.

Registry
clinicaltrials.gov
Start Date
June 2011
End Date
August 2012
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female, aged 30 to 65 years.
  • Subject in good health.
  • Mild to moderate skin laxity around the knees.
  • Understands and accepts the obligation not to undergo any other procedures in the areas to be treated through the follow-up period.

Exclusion Criteria

  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Excessive subcutaneous fat around the knees.
  • Excessive skin laxity around the knees.

Outcomes

Primary Outcomes

Improvement in overall lifting and tightening of knee skin laxity.

Time Frame: 90 and 180 days post-treatment

Assessed based on Principal Investigator assessment using the Global Aesthetic Improvement Scale.

Secondary Outcomes

  • Overall improvement in skin laxity.(90 and 180 days post-treatment)

Study Sites (1)

Loading locations...

Similar Trials